slides · global inventory
Image
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 119,566
Current window 82,201-82,230
Pages 3,986
Rows per page 30
Component
82,201-82,230 of 119,566
28
This slide serves as the 'before' state in a before-after transformation narrative.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
29
Includes brand strategy pillars and financial targets (revenue growth and gross margin expansion).Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
30
Includes a donut chart representing channel mix and key growth metrics.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
40
Levi Strauss | Investor Presentation Deck | 49 slidesLevi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
41
Levi Strauss | Investor Presentation Deck | 49 slidesLevi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
42
Levi Strauss | Investor Presentation Deck | 49 slidesLevi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations 1 hit
01
Exhibit 99.1 indicates this is likely a regulatory or investor relations document.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
02
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
06
The slide presents a snapshot of company growth from 2019 to Q2 2022, including instrument shipments, manufacturing capacity, market reach, and revenue.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
09
The slide uses a list of pain points on the left and illustrative examples of existing POC devices on the right.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
10
Uses a photo of a lab bench to illustrate the 'proliferation of instruments' pain point.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
11
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
15
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
16
The visual shows four distinct test strips (INR, D-Dimer, SARS CoV-2 Ab, SARS CoV-2 Ag) to demonstrate the 'common architecture' claim.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
18
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
19
The chart uses a bar-vertical format to show relative pricing, with LumiraDx POC positioned as significantly cheaper than other POC solutions.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
21
The slide uses a horizontal arrow at the bottom to represent the strategic shift toward 'Decentralization'.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
26
The slide uses a bulleted list for key value propositions and a table to demonstrate clinical sensitivity (PPA) across different Ct value thresholds.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Evidence1 hit
31
The slide illustrates a 3-step process: Prep Sample, Load & Run, and Report Results, with a timeline of 1 minute for prep and 2-12 minutes for results.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
32
Uses a visual 'before/after' style comparison with red X marks to indicate legacy/displaced systems.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
34
The slide uses a product-centric layout to demonstrate market readiness and addressable market size for a portfolio of diagnostic tests.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
39
The slide uses a horizontal progression to illustrate the shift from centralized lab testing to decentralized home testing.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
41
The slide uses a process-like flow to categorize product applications.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
42
The diagram is a circular process flow showing the integration of hardware, software, and pharmacy services.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
44
The slide highlights current reach and future expansion plans into major diagnostics markets.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
53
The slide displays the LumiraDx platform hardware alongside a row of 10 distinct test cartridges (SARS-CoV-2 variants, HbA1c, D-Dimer, INR, NT-proBNP, CRP).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
55
This is a transition or filler slide used for branding.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
30
Morgan Stanley | Investment Banking Pitch Book | 30 slidesMorgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank 1 hit
01
Includes standard Morgan Stanley confidential treatment disclosure.Morgan Stanley | Investment Banking Pitch Book | 8 slides · Morgan Stanley
Consulting deck Investment bank Beat · Situation & ContextLoop · Cost Of Inaction1 hit
04
Nexters | Results Presentation Deck | 14 slidesNexters | Results Presentation Deck | 14 slides · Nexters
Conference presentation Investor relations Beat · Current State1 hit